NCT01969669View on ClinicalTrials.gov

A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

ABT-199

Subjects will be dosed with ABT-199, then dosed with ABT-199 in combination with ketoconazole

DRUG

Ketoconazole

Subjects will be dosed with ABT-199, then dosed with ABT-199 in combination with ketoconazole

Trial Locations (3)

85724-5024

Site Reference ID/Investigator# 97498, Tucson

03756-0001

Site Reference ID/Investigator# 92593, Lebanon

07601

Site Reference ID/Investigator# 101415, Hackensack

Sponsors

Lead Sponsor

AbbVie

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

AbbVie

INDUSTRY